Moderna says its Covid-19 vaccine was well-tolerated and generated robust immune response in children ages 6 to 11
CNN
Interim results of a Phase 2/3 trial showed Moderna's Covid-19 vaccine was well-tolerated and generated a robust immune response in children ages 6 to 11, the company said Monday.
The trial included more than 4,700 participants between the ages of 6 and 11, and looked at two 50-microgram doses of Moderna's vaccine given 28 days apart. This is smaller than the 100-microgram dose given to adults. The company compared the antibody response in younger children to the response in young adults in the company's Phase 3 trial, and found a "strong immune response in this cohort of children one month after the second dose."
Senate Democrats have confirmed some of President Joe Biden’s picks for the federal bench this week in the face of President-elect Donald Trump’s calls for a total GOP blockade of judicial nominations – in part because several Republicans involved with the Trump transition process have been missing votes.
Donald Trump is considering a right-wing media personality and people who have served on his US Secret Service detail to run the agency that has been plagued by its failure to preempt two alleged assassination attempts on Trump this summer, sources familiar with the president-elect’s thinking tell CNN.